Current and emerging medical therapies for glaucoma

JC Tsai, EM Kanner - Expert opinion on emerging drugs, 2005 - Taylor & Francis
Glaucoma is a multifactorial optic neuropathy in which there is a characteristic acquired loss
of retinal ganglion cells, at levels beyond normal age-related baseline loss, and …

Changing therapeutic paradigms in glaucoma management

R David - Expert opinion on investigational drugs, 1998 - Taylor & Francis
Glaucoma is a family of diseases commonly characterised by progressive optic neuropathy
with associated visual field deficits for which elevated intraocular pressure (IOP) is one of the …

Current medical therapy and future trends in the management of glaucoma treatment

B Cvenkel, M Kolko - Journal of Ophthalmology, 2020 - Wiley Online Library
Glaucoma is a neurodegenerative disease characterized by progressive loss of retinal
ganglion cells and their axons. Lowering of intraocular pressure (IOP) is currently the only …

Emerging drugs for the treatment of glaucoma: a review of phase II & III trials

TM Kaplan, AJ Sit - Expert Opinion on Emerging Drugs, 2022 - Taylor & Francis
Introduction Glaucoma is a progressive optic neuropathy and the leading cause of
irreversible vision loss. By 2040, the number of individuals with glaucoma is expected to …

[HTML][HTML] Recently approved drugs for lowering and controlling intraocular pressure to reduce vision loss in ocular hypertensive and glaucoma patients

NA Sharif - Pharmaceuticals, 2023 - mdpi.com
Serious vision loss occurs in patients affected by chronically raised intraocular pressure
(IOP), a characteristic of many forms of glaucoma where damage to the optic nerve …

Changing paradigms in the medical treatment of glaucoma

JB Soltau, TJ Zimmerman - Survey of Ophthalmology, 2002 - Elsevier
Glaucoma is defined by a typical optic neuropathy accompanied by characteristic visual field
loss and eventual blindness. The major risk factor for glaucoma is elevated intraocular …

[PDF][PDF] Current management of glaucoma and the need for complete therapy

SJ McKinnon, LD Goldberg, P Peeples, JG Walt… - Am J Manag Care, 2008 - aoa.org
Glaucoma is a long-term ocular neuropathy defined by optic disc or retinal nerve fiber
structural abnormalities and visual field abnormality. Primary open-angle glaucoma is the …

Glaucoma management: relative value and place in therapy of available drug treatments

D Sambhara, AA Aref - Therapeutic advances in chronic …, 2014 - journals.sagepub.com
Lowering intraocular pressure (IOP) is the only proven therapeutic intervention for
glaucomatous optic neuropathy. Despite advances in laser and microsurgical techniques …

Glaucoma: a brief review

N Schellack, S Bezuidenhout - SA Pharmaceutical Journal, 2015 - journals.co.za
Glaucoma is a complex condition of the eye. It is an ophthalmic neurodegenerative condition
and is characterised by raised intraocular pressure. When left untreated, patients may …

Pharmacotherapy of glaucoma

D Schmidl, L Schmetterer, G Garhöfer… - Journal of Ocular …, 2015 - liebertpub.com
Glaucoma is a group of diseases involving the optic nerve and associated structures, which
is characterized by progressive visual field loss and typical changes of the optic nerve head …